Discover

WHWK
Whitehawk Therapeutics Inc
4.72
1 x 4.72
1 x 4.74
bid
ask
+
0.17
3.74%
02:54 PM
timesize
Ytd95.04%
1y179.29%
4.22
day range
4.80
1.57
52 week range
5.50
Open4.56Prev Close4.55Low4.22High4.80Mkt Cap269.65M
Vol735.16KAvg Vol543.30KEPS-1.12P/E-4.22Forward P/EN/A
Beta0.76Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg4.12200-d Avg3.381yr Est0.00
Income Statement
Operating Expenses18.11M
Research and Development Expense12.89M
Selling, General and Administrative Expense5.22M
Operating Income-18.11M
Net Income-16.64M
Net Income Common Stock-16.64M
Net Income Common Stock (USD)-16.64M
Consolidated Income-16.64M
Earnings per Basic Share-0.20
Earnings per Basic Share (USD)-0.20
Earnings per Diluted Share-0.20
Earning Before Interest & Taxes (EBIT)-16.64M
Earning Before Interest & Taxes (USD)-16.64M
Weighted Average Shares82.89M
Weighted Average Shares Diluted82.89M
Balance Sheet
Cash and Equivalents85.23M
Cash and Equivalents (USD)85.23M
Investments104.75M
Investments Current104.75M
Current Assets192.41M
Property, Plant & Equipment Net1000
Total Assets193.99M
Current Liabilities11.07M
Total Liabilities11.07M
Accumulated Retained Earnings (Deficit)-392.08M
Accumulated Other Comprehensive Income-63.00K
Shareholders Equity182.93M
Shareholders Equity (USD)182.93M
Assets Non-Current1.58M
Trade and Non-Trade Payables1.11M
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow from Financing81.84M
Net Cash Flow / Change in Cash & Cash Equivalents50.44M
Issuance (Purchase) of Equity Shares81.93M
Net Cash Flow from Investing-16.87M
Net Cash Flow - Investment Acquisitions and Disposals-16.87M
Net Cash Flow from Operations-14.53M
Share Based Compensation1.52M